If you don't remember your password, you can reset it by entering your email address and clicking the Reset Password button. You will then receive an email that contains a secure link for resetting your password
If the address matches a valid account an email will be sent to __email__ with instructions for resetting your password
Metabolism promotes excellence in research by publishing high-quality original research papers, fast-tracking cutting-edge papers, research brief reports, mini-reviews, and other special articles related to all aspects of human metabolism. Work considered for publication in Metabolism includes studies in humans, animal and cellular models. Work with strong translational potential is prioritized. Metabolism will consider papers for publication in any aspect of translational and clinical metabolic research, including (but not limited to):
Christos S. Mantzoros, MD, DSc, PhD h.c. mult. is Professor of Medicine at Harvard Medical School and Boston University School of Medicine. He has also served as a Professor of Environmental Health at the Harvard School of Public Health. He currently serves as the Chief of Endocrinology, Diabetes and Metabolism at the Boston VA Healthcare System and the Director of Human Nutrition at Beth Israel Deaconess Medical Center. He had served and continues to serve as Endocrinology and Metabolism Fellowship Program Director and Founding Director. He has mentored in his own laboratory more than 175 young scientists who currently hold key positions in clinical medicine, academia and industry, as well as governmental agencies and nongovernmental organizations.
As Editor-in-Chief of Metabolism: Clinical and Experimental, I'm happy to share some great news about the journal.
Our Impact Factor has been continuously increasing over the past ten years that I have been serving at the helm, and is now at 8.7, placing the journal amongst the top 7% of endocrinology, diabetes, and metabolism journals as indexed in Journal Citation Reports*. Similarly, cited half-life, or the duration an average paper continues receiving citations, has also increased significantly and is in the top 7% of endocrinology, diabetes, and metabolism journals.
The COVID-19 pandemic presents an unprecedented health crisis to the entire world. As in many other instances, people with metabolic syndrome (obesity, hypertension, hyperlipidemia, and diabetes) are apparently paying a very high price.
Data, albeit mostly uncontrolled for potential confounding factors, are, unfortunately, showing that people with underlying metabolic conditions are at higher risk of both contracting COVID-19 and having a worse prognosis. At the same time, in such a sudden health crisis, it is not clear what the most appropriate management would be and thus most likely these patients may not be receiving the most appropriate care when hospitalized.
Metabolism is committed to playing a positive role during this crisis. We the Editors invite the submission of papers addressing this topic and remain committed to a fast-track quality process for the review of any relevant research on COVID-19 and guarantee free access to accepted papers.
Dr. Zhu received his Sc.D degree at the Harvard T.H.Chan School of Public Health, Boston, MA, USA. He is currently an Assistant Professor of Emergency Medicine at Massachusetts General Hospital/Harvard Medical School in Boston, MA, USA.
Dr. Vargas-Castillo obtained her Ph.D in Neuropharmacology and Experimental Therapeutics at CINVESTAV-IPN and the National Institute of Medical Sciences and Nutrition Salvador Zubiran in Mexico. She is currently a Postdoctoral fellow in Bruce Spiegelman’s laboratory at the Dana Farber Cancer Institute and Harvard Medical School, Massachusetts, USA.